Evidence map›Paper›PMID 42676320›Full record

ReviewLe Mali medical2025

[BRCA1 Gene's Mutations And Hereditary Breast Cancer: Genetic, Biological, And Clinical Aspects].

Fatoumata Korika Tounkara, Ibrahima Téguété, Fatoumata Matokoma Sidibé, Dapa Aly Diallo

Abstract readEnglish AbstractReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Le Mali medical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatoumata Korika TounkaraUniversity des Sciences des Techniques et des Technologies de Bamako (USTTB), Mali.
Ibrahima TéguétéUniversity des Sciences des Techniques et des Technologies de Bamako (USTTB), Mali.
Fatoumata Matokoma SidibéService d'Oncologie Médicale, Centre Hospitalier Universitaire du Point «G», Bamako, Mali.
Dapa Aly DialloUniversité Kankou Moussa, Faculté Mixte des Sciences de la Santé, Bamako, Mali.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hereditary breast cancer accounts for approximately 5 to 10% of all breast cancer cases. Mutations in the Methods: A narrative literature review was conducted using biomedical databases (PubMed, Scopus, Web of Science, Google Scholar) between January 2024 and June 2025. Eligible publications addressed the genetic, biological, epidemiological, and clinical aspects of Results: Conclusion: A comprehensive understanding of

Indexed as

BRCA1 ProteinBreast NeoplasmsGenes, BRCA1FemaleGenetic Predisposition to DiseaseGenetic TestingGerm-Line MutationHumansMutationTriple Negative Breast NeoplasmsBRCA1 ProteinBRCA1 protein, humanBRCA1hereditary breast cancermutationpreventiontargeted therapytriple-negative breast cancer

Identifiers

PMID42676320
PMCPMC13103453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.